Evidence map›Paper›PMID 36920243›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice.

Alex Broom, Leah Williams Veazey, Katherine Kenny, Imogen Harper, Michelle Peterie, Alexander Page, Nicole Cort, Jennifer Durling, Eric S Lipp, Aaron C Tan and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. COVID-19 and cancer: reflections 2 years into the pandemic.Korean journal of clinical oncology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 3 countries.

Alex BroomSydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0003-1258-1140
Leah Williams VeazeySydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-0173-3690
Katherine KennySydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-9088-5671
Imogen HarperSydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-3019-5123
Michelle PeterieSydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0002-7182-7246
Alexander PageSydney Centre for Healthy Societies, School of Social and Political Sciences, The University of Sydney, Sydney, New South Wales, Australia.ORCID 0000-0001-5674-4517
Nicole CortDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0001-8434-5994
Jennifer DurlingDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-8483-0858
Eric S LippDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-4372-5533
Aaron C TanDivision of Medical Oncology, National Cancer Centre Singapore, Singapore.ORCID 0000-0001-7292-1114
Kyle M WalshDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-5879-9981
Brent A HanksDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-2803-3272
Margaret JohnsonDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0003-1208-622X
Amanda E D Van SwearingenDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-4287-9741
Carey K AndersDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0001-9165-4074
David M AshleyDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0002-4754-5900
Mustafa KhasrawDuke Cancer Institute, Duke University Medical Center, Durham, North Carolina.ORCID 0000-0003-3249-9849
Duke Medical Center · USThe University of Sydney · AUNational Cancer Centre Singapore · SG

Funding

Women's Cancer Research ProgramP30CA014236 · NCI · DUKE UNIVERSITY · PI Laura Fish · 1985 to 2026
$174.8M
NCI NIH HHS P30 CA014236
6 · The paper itself

Abstract

For three years, COVID-19 has circulated among our communities and around the world, fundamentally changing social interactions, health care systems, and service delivery. For people living with (and receiving treatment for) cancer, pandemic conditions presented significant additional hurdles in an already unstable and shifting environment, including disrupted personal contact with care providers, interrupted access to clinical trials, distanced therapeutic encounters, multiple immune vulnerabilities, and new forms of financial precarity. In a 2020 perspective in this journal, we examined how COVID-19 was reshaping cancer care in the early stages of the pandemic and how these changes might endure into the future. Three years later, and in light of a series of interviews with patients and their caregivers from the United States and Australia conducted during the pandemic, we return to consider the potential legacy effects of the pandemic on cancer care. While some challenges to care provision and survivorship were unforeseen, others accentuated and amplified existing problems experienced by patients, caregivers, and health care providers. Both are likely to have enduring effects in the "post-pandemic" world, raising the importance of focusing on lessons that can be learned for the future.

Indexed as

COVID-19NeoplasmsAustraliaHumansPandemics

Identifiers

PMID36920243
PMCPMC10150237
OpenAlexW4324311269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.